|1.||McNeel, Douglas G: 8 articles (07/2014 - 12/2005)|
|2.||Small, Eric J: 7 articles (08/2015 - 10/2003)|
|3.||Lin, Ming-Fong: 7 articles (01/2015 - 02/2003)|
|4.||Johnson, Laura E: 6 articles (07/2014 - 01/2006)|
|5.||Lin, Fen-Fen: 5 articles (01/2015 - 02/2003)|
|6.||Lin, M F: 5 articles (11/2001 - 01/2000)|
|7.||Vihko, Pirkko: 4 articles (01/2014 - 10/2008)|
|8.||Kirchhoff, Frank: 4 articles (01/2012 - 07/2009)|
|9.||Fong, Lawrence: 4 articles (05/2007 - 10/2003)|
|10.||Lee, M S: 4 articles (11/2001 - 01/2000)|
|1.||Prostatic Neoplasms (Prostate Cancer)
02/01/1993 - "Previously, prostatic acid phosphatase (PAP) was used to help diagnose and monitor the efficacy of therapy for prostate cancer. "
07/01/1983 - "We compared a commercial radioimmunoassay kit with an enzymatic assay for prostatic acid phosphatase in monitoring the progression or remission of disease in 27 patients with prostatic cancer. "
08/01/1981 - "[Improved diagnostic evaluation of prostatic neoplasms using radioimmunoassay for prostatic acid phosphatase]."
07/01/2002 - "Another study examined this issue by studying prostatic acid phosphatase (PAP) protein-loaded mature DCs injected intravenously, intradermally, and intralymphatically in prostate cancer patients . "
01/01/1992 - "In this study twenty male urethral specimens were evaluated for PSA and prostatic acid phosphatase (PAP) from patients without evidence of prostatic cancer. "
02/15/2003 - "The objective of this study was to define the long-term prognostic significance of prostatic acid phosphatase (PAP) levels in patients with higher risk, early-stage prostate carcinoma. "
06/01/2002 - "The level of prostatic acid phosphatase in serum is an established marker for prostate carcinoma. "
11/01/1999 - "Prognostic role of serum prostatic acid phosphatase for 103Pd-based radiation for prostatic carcinoma."
04/28/1995 - "The expression of prostatic acid phosphatase is transcriptionally regulated in human prostate carcinoma cells."
02/01/1995 - "An open biopsy revealed undifferentiated tissue that stained strongly positive for prostatic-specific acid phosphatase, confirming the diagnosis of metastatic prostate carcinoma."
06/01/1983 - "No major adverse effects were noted with this treatment modality, and all patients were symptomatically improved and demonstrated a decrease or stabilization in tumor activity as measured by prostatic computerized tomography or ultrasound scan, prostatic acid phosphatase and bone scan. "
04/01/1999 - "On the basis of this blinded study, RT-PCR for PSA-expressing cells in 85 patients before RP is not related to clinical stage, age, race, grade, Gleason sum, serum PSA or prostatic acid phosphatase, tumor volume, or tumor multifocality. "
09/01/2015 - "Our results document the suppression of subcutaneous tumor growth in animals immunized with AAV6-S663V+T492V vectors expressing prostatic acid phosphatase (PAP) for approximately 4 weeks in comparison with 1 week and 2 weeks for the negative controls, AAV6-EGFP, and AAV6-WT-PAP treated mice, respectively. "
08/01/2014 - "Cellular prostatic acid phosphatase, a PTEN-functional homologue in prostate epithelia, functions as a prostate-specific tumor suppressor."
07/01/2012 - "Immunohistochemical staining with PSA and Prostatic Acid Phosphatase (PAP) can help in establishing prostatic nature of the neoplasm. "
07/01/1984 - "Pain was improved and serum prostatic acid phosphatase levels had decreased significantly, and by 1 month prostatic acid phosphatase had reached the normal range. "
05/01/1999 - "A 62-year-old man was referred to our department because of abnormal prostatic acid phosphatase and pain in his right upper arm. "
01/01/1993 - "The combination regimen produced a more rapid normalisation of prostatic acid phosphatase levels and a prompt relief of bone pain. "
11/01/2013 - "Prostatic acid phosphatase (PAP) has been considered as a diagnostic marker for prostate cancer and its transmembrane isoform has been reported to play an antinociceptive effect in neuropathic and inflammatory pain. "
11/01/2013 - "Antinociceptive effect of prostatic acid phosphatase in a rat model of cancer-induced bone pain."
05/01/1985 - "Furthermore, under electron microscopic study, prostatic specific acid phosphatase granules were uniformly and intensely condensed in intracytoplasmic vacuoles in well differentiated adenocarcinomas, whereas in moderately or poorly differentiated adenocarcinomas 2 types of staining were observed. "
03/01/1980 - "Results of such a study show an increased diagnostic sensitivity of the radioimmunoassay in all stages, but in 14% of Stage IV adenocarcinomas there was no increase in prostatic acid phosphatase above the ranges ordinarily expected for all methods. "
01/01/2013 - "Transmembrane prostatic acid phosphatase (TMPAP) interacts with snapin and deficient mice develop prostate adenocarcinoma."
07/01/1987 - "The usefulness of clinical stage, serum prostatic acid phosphatase and preoperative Gleason grade in predicting final pathological stage in patients with adenocarcinoma of the prostate remains controversial. "
07/01/1987 - "Correlation of clinical stage, serum prostatic acid phosphatase and preoperative Gleason grade with final pathological stage in 275 patients with clinically localized adenocarcinoma of the prostate."
|1.||Prostate-Specific Antigen (Semenogelase)
|4.||Biological Markers (Surrogate Marker)
|6.||Biological Tumor Markers (Tumor Markers)
|7.||Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)
|8.||DNA (Deoxyribonucleic Acid)
|9.||A-Form DNA (A-DNA)
|10.||Heat-Shock Proteins (Heat-Shock Protein)
|3.||Prostatectomy (Retropubic Prostatectomy)